This study evaluates the safety and tolerability of Renaparin in adult patients receiving a
deceased donor kidney treated ex-vivo with Renaparin prior to transplantation. Half the
patient group will receive a kidney treated with Renaparin, while the other half of the
patient group will receive a kidney treated with placebo.